BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Dynatronics Corporation Announces Leadership Transition

  Dynatronics Corporation announced leadership changes to its Board of Directors and executive management team, including the separation of its chairmanship and chief executive officer positions

  February 21, 2018

   · 

  7 min read
• Genetown

  Millions of U.S. Allergy Sufferers Now Have Access to Advanced Diagnostic Tests

  PlushCare’s highly trained telehealth physicians can now conveniently order Thermo Fisher Scientific blood allergy tests for patient diagnosis and treatment

  February 21, 2018

   · 

  3 min read
• Business

  Elysium Health™ Welcomes Two New Board Members

  Industry innovator developing clinically proven health products adds award-winning behavioral economist Daniel Kahneman, Ph.D., to its scientific advisory board and healthcare leader Gary Gottlieb, M.D., to its board of directors.

  February 21, 2018

   · 

  3 min read
• Drug Development

  Aldeyra Therapeutics Selected for Podium Presentation of Phase 2a Dry Eye Disease Results at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

  Poster Presentations to Feature Phase 2b Allergic Conjunctivitis Results, in Addition to Activity of Reproxalap and ADX-103 in Models of Retinal Inflammation, Diabetic Macular Edema, and Dry Age-Related Macular Degeneration

  February 21, 2018

   · 

  9 min read
• Drug Development

  ORIC Pharmaceuticals Announces $50 Million Series C Financing to Support Novel Therapies for Treatment-Resistant Cancers

  Proceeds from the investment will be used to support clinical studies of ORIC-101, a potent small molecule inhibitor of the glucocorticoid receptor (GR) and the subject of an ongoing Phase 1 study.

  February 21, 2018

   · 

  3 min read
• Global Monoclonal Antibodies Market Hit $100 Billion in 2017: Report

  The global market for monoclonal antibodies (mAbs) - large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances - topped $100 billion in 2017, according to Kalorama Information.

  February 21, 2018

   · 

  5 min read
• Business

  ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

  ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the company’s Leap-In cell line development tools.

  February 21, 2018

   · 

  2 min read